The Cerba Research team will attend the 18th WRIB workshop meeting, from 6 May to 10 May in San Antonio. Over a span of four days, our experts will be ready to meet you at our booth, nr. 3! Would you like to register to this event? Check here.

The 18th WRIB (Workshops on Recent Issues in Bioanalysis) builds further on the success of the previous meetings, where 1000 professionals representing pharma/biotech companies, CROs, and multiple regulatory agencies convene to discuss current topics of interest in bioanalysis. High Quality, better compliance with regulations, and scientific excellence have always been the foundations of WRIB.

Engage with our team of experts to discuss the latest scientific, regulatory, and innovative insights on:

Bioanalytical assay development/validation services for large molecules, biologics and biosimilars

Biomarker services

(Early-stage) Immunogenicity testing services for vaccines, biologics and gene therapies

Supporting services, including global central laboratory and logistics capabilities

…. and more

Learn more about our bioanalysis and biomarker services.

Our Experts Attending WRIB

Visit us at booth 3, where you can meet our experts.

About Cerba Research

Cerba Research’s bioanalytical business unit (previously known as Cirion is highly recognized for its integrated bioanalytical and global central laboratory services. Supported by the latest techniques and high end facilities, including a large GLP certified facility (35,000 sq/f or 3,250 sq/m). The company has a long-standing experience in supporting biologics and biosimilar [link to: [https://cerbaresearch.com/therapeutic-scientific-expertise/biologics-and-biosimilars/] drug development for market authorization applications with various regulatory authorities such as, but not limited to, FDA, EMA, Health Canada, Japanese and Australian authorities (PMDA and TGA, respectively).

Our Accreditations:

College of American Pathologists (CAP)
Clinical Laboratory Improvement Amendments (CLIA) accreditation in the USA (CLIA #99D2079197)
Additional clinical laboratory permits and licenses delivered from Maryland, New York, Pennsylvania, California, and Rhode Island.
GLP certified: Standard Councils of Canada (SCC), the Canadian monitoring authority for OECD.
Lipid standardization program for center for disease control (LPS CDC)
NGSP HbAc1 level 1 certification: National glycohemoglobin standardization program